ARK Genomic Revolution ETF
ARKGDividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 31, 2021 | $0.38 | 2021-12-29 | 2021-12-30 |
| December 31, 2020 | $0.79 | 2020-12-29 | 2020-12-30 |
| December 31, 2019 | $1.05 | 2019-12-27 | 2019-12-30 |
| December 31, 2018 | $0.20 | 2018-12-27 | 2018-12-28 |
| December 31, 2018 | $0.27 | 2018-12-27 | 2018-12-28 |
Dividends Summary
- Consistent Payer: ARK Genomic Revolution ETF has rewarded shareholders with 7 dividend payments over the past 4 years.
- Total Returned Value: Investors who held ARKG shares during this period received a total of $3.02 per share in dividend income.
- Latest Payout: The most recent dividend of $0.38/share was paid 1484 days ago, on December 31, 2021.
- Yield & Schedule: ARKG currently pays dividends yearly with an annual yield of 1.12%.
- Dividend Growth: Since 2017, the dividend payout has grown by 98.4%, from $0.19 to $0.38.
Company News
The FDA approved Guardant Health's Guardant360 CDx blood test as a companion diagnostic to identify patients with BRAF V600E-mutant metastatic colorectal cancer who may benefit from Pfizer's Braftovi treatment combined with cetuximab and chemotherapy. This marks the 25th companion diagnostic indication for the platform and expands non-invasive ge...
Tempus AI stock rose 10.9% this week after Ark Invest ETFs added shares to their portfolios and a BTIG analyst raised the price target to $105, indicating potential growth in AI healthcare technology.
This article provides the daily fund prices for various WisdomTree ETFs as of March 26, 2025. It covers a wide range of ETFs, including those focused on artificial intelligence, bonds, commodities, equities, and emerging markets.
Cathie Wood's Ark Invest offers several actively managed ETFs focused on different tech-related sectors. While her funds have had strong performance, they have been light on AI-focused investments. This article provides an overview of Ark's largest ETFs and their top holdings.
Ark Funds, managed by Cathie Wood, have underperformed the broader market in recent years due to their focus on volatile technology sectors that require a specific economic environment to thrive. The funds' high turnover and concentration risks have also contributed to their underperformance.
